FEQIX
Price
$77.06
Change
+$0.56 (+0.73%)
Updated
Jan 23 closing price
Net Assets
8.79B
RMEBX
Price
$57.15
Change
+$0.51 (+0.90%)
Updated
Jan 23 closing price
Net Assets
104.41B
Ad is loading...

FEQIX vs RMEBX

Header iconFEQIX vs RMEBX Comparison
Open Charts FEQIX vs RMEBXBanner chart's image
Fidelity Equity-Income
Price$77.06
Change+$0.56 (+0.73%)
VolumeN/A
Net Assets8.79B
American Funds American Mutual R2E
Price$57.15
Change+$0.51 (+0.90%)
VolumeN/A
Net Assets104.41B
FEQIX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEQIX vs. RMEBX commentary
Jan 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEQIX is a Buy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 104B vs. FEQIX (8.79B). FEQIX (1.59) and RMEBX (1.54) have matching dividends . FEQIX was incepted earlier than RMEBX: FEQIX (59 years) vs RMEBX (10 years). RMEBX is a more actively managed with annual turnover of: 25.00 vs. FEQIX (17.00). FEQIX has a lower initial minimum investment than RMEBX: FEQIX (0) vs RMEBX (250). FEQIX annual gain was more profitable for investors over the last year : 16.51 vs. RMEBX (13.63). RMEBX (40.60) and FEQIX (38.84) have equivalent 5 years return.
FEQIXRMEBXFEQIX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence59 years10 years-
Gain YTD4.6024.098112%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.79B104B8%
Annual Yield % from dividends1.591.54103%
Returns for 1 year16.5113.63121%
Returns for 3 years19.4216.79116%
Returns for 5 years38.8440.6096%
Returns for 10 years43.7764.9767%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLR174.112.21
+1.29%
First Solar
AAMI25.660.26
+1.02%
Acadian Asset Management Inc
SHC13.690.09
+0.66%
Sotera Health Company
VERI3.15-0.03
-0.94%
Veritone
ACXP0.83-0.02
-2.36%
Acurx Pharmaceuticals